Frequently encountered alterations include MDM2 amplification for well-/dedifferentiated liposarcomas, MYC amplification for radiation induced angiosarcoma or segmental chromosomal deletions on chromosome 22q encompassing SMARCB1 for rhabdoid tumours. This evidence concerns the gene SMARCB1 and liposarcoma.